Baidu
map

JAMA:指南:女性该怎样进行乳腺癌风险筛查?

2015-10-21 MedSci MedSci原创

据美国癌症协会最新发表的乳腺癌指南,女性在40岁以后应每年定时筛查乳腺癌,且应持续到55岁以后。这份新的乳腺癌指南发表在JAMA。自2003年更新乳腺癌预防指南以来,美国癌症协会(ACS)指出,女性患乳腺癌的发病率逐年降低。ACS指出,有罹患乳腺癌风险的女性应从45岁起每年进行乳房x光检查进行乳腺癌风险筛查(也有人认为应该提早进行筛查风险),55岁以上的女性应该隔年进行一次乳房x光检查(也有人认为

据美国癌症协会最新发表的乳腺癌指南,女性在40岁以后应每年定时筛查乳腺癌,且应持续到55岁以后。这份新的乳腺癌指南发表在JAMA。

自2003年更新乳腺癌预防指南以来,美国癌症协会(ACS)指出,女性患乳腺癌的发病率逐年降低。ACS指出,有罹患乳腺癌风险的女性应从45岁起每年进行乳房x光检查进行乳腺癌风险筛查(也有人认为应该提早进行筛查风险),55岁以上的女性应该隔年进行一次乳房x光检查(也有人认为应每年进行一次)。 

乳腺癌是美国妇女的患癌死亡的第二大原因,仅次于肺癌死亡率。据估计,2015年将有23万名美国妇女罹患乳腺癌,且40300名女性将死于乳腺癌。 

自1990年以来,乳腺癌死亡率逐年下降,这很大程度上是由于早期检查、筛选和治疗方案改进的缘故。人们认为,早期发现乳腺癌是治疗乳腺癌并提高癌症患者生存率和生活质量的关键。 

这份改进的乳腺癌指南是在众多乳腺癌研究的基础上,总结研究结论的利与弊,并归纳得出的。主要内容如下:

40-44岁的女性可随意选择是否每年进行乳房x光检查;
45岁后女性应定期进行乳房x光筛查;
45-54岁的女性应每年进行乳房x光筛查;
55岁以上的女性应每隔1-2年进行一次乳房x光筛查;
若老年女性的身体健康,预期可继续生活10年以上者,可持续进行乳腺癌风险筛查(但也有人认为应停止筛查,以让老人安度晚年)。 

研究人员指出,40岁以上的女性要积极进行如防风险筛查,最常见的采用乳房x光片。活检或侵入性治疗都可对女性造成不必要的感染风险。ACS的建议旨在最大可能降低乳腺癌患者死亡率同时,又可减少对人们的机体损害。 


(图片来源:JAMA)

原始出处:

New guidelines for breast cancer screening age.Medical News Today.Oct 20, 2015.

Kevin C. Oeffinger et al.Breast Cancer Screening for Women at Average Risk.JAMA.Oct 2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2016-03-19 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-11-12 静秋

    挺好还是定期体检

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-22 owlhealth

    挺好的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 pine007

    好?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 medcardio

    按不同年龄进行分别筛查

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2061483, encodeId=fd13206148362, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 19 11:58:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770238, encodeId=6e3a1e70238f3, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sat Jul 30 06:58:00 CST 2016, time=2016-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=43038, encodeId=599e43038a3, content=挺好还是定期体检, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ec41662774, createdName=静秋, createdTime=Thu Nov 12 08:19:00 CST 2015, time=2015-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40268, encodeId=554c4026873, content=挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Thu Oct 22 13:05:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40146, encodeId=34354014627, content=好?, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b531630898, createdName=pine007, createdTime=Wed Oct 21 21:44:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40084, encodeId=a96b40084e7, content=按不同年龄进行分别筛查, beContent=null, objectType=article, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Wed Oct 21 19:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40064, encodeId=afce40064d1, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 13:49:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 lixh1719

    实用

    0

相关资讯

BMJ:乳腺癌的早期诊断很重要--基于17万病例的研究结果

近期有研究者通过荷兰全国癌症登记信息,进行了一项以全国人口为基础的前瞻性研究,探究在拥有更好效果的辅助治疗的当今时代,乳腺癌确诊时分期情况、肿瘤生物学性质等对预后的影响。该研究纳入了1999-2012年共计n=173 797名诊断为原发性乳腺癌的女性患者,根据诊断时间将其分为2个亚组队列:1999-2005年n=80 228;2006-2012年n=93 569。研究者对两个队列进行生存率比较,且

Lancet:二磷酸盐可减少乳腺癌骨转移

磷酸盐可以对骨骼的生理产生影响,从而修改转移的过程。研究者为探究二磷酸盐辅助治疗乳腺癌的利和弊,进行了一项荟萃分析。研究者纳入早期乳腺癌患者,随机分为二磷酸盐组和对照组。以复发、远处转移、乳腺癌死亡率作为初始结局指标。以下情况分亚组:远处转移位置(骨或其他)、月经状态 (自然或人工绝经后、非绝经)、二磷酸盐类别(亚甲基氨基二膦酸盐或其他)。研究共纳入18,766名女性,其中18,206 [97%]

Lancet Oncol:Etirinotecan pegol治疗乳腺癌效果分析

乳腺癌患者需要寻找新的方法来对该病进行治疗。Etirinotecan pegol是一种长效的拓扑异构酶I抑制剂,可以延长肿瘤细胞对于SN38(该药的活性成分)的暴露时间,但同时也降低了SN38浓度过高所带来的毒性效应。研究人员意在评估Etirinotecan pegol对局部复发的或转移性乳腺癌患者的治疗效果是否优于传统疗法。在11个国家的135处实验室处进行随机且开放式的,并且是多中心的3期临床

PLoS ONE:牛身上病毒如何引发人类乳腺癌的发生?

图片来源:medicalxpress.com来自加利福尼亚大学的科学家近日通过研究首次发现感染牛白血病病毒和人类乳腺癌发病之间的神秘关联,相关研究发表于国际杂志PLoS ONE上,文章中研究者对239名女性患者的乳腺组织进行分析,对比了乳腺癌患者的样本组织和无疾病史但感染牛白血病病毒(BLV)个体的组织样本的差异,结果发现,59%的乳腺癌患者机体样本中都检测出了BLV的病毒DNA,随后通过进一步对

CEBP:不同乳腺癌亚型之间的差异性 或帮助新型疗法的开发

少数民族女性,尤其是非洲裔美国人、西班牙白人和美洲印第安人,往往容易被诊断为恶性乳腺癌,而这些患者不太可能接受推荐的方案进行治疗,因此其更容易因乳腺癌而死亡;此前研究中研究人员阐明了不同阶段疾病及患者死亡率之间的不一致性,但并没有对疾病的亚型进行分析对比。 刊登在国际杂志Cancer Epidemiology,Biomarkers & Prevention的一项研究论文中,来自西雅图Fr

Lancet:早期乳腺癌内分泌治疗——芳香化酶抑制剂 vs 他莫昔芬(Meta)

临床上对于早期乳腺癌患者内分泌治疗的优先选择尚不明确,究竟是选芳香化酶抑制剂还是他莫昔芬。研究者就该问题进行了一项荟萃分析,涉及31,920 名绝经后、雌激素受体阳性的早期乳腺癌患者,随机进行了长达5年的芳香化酶抑制剂 vs 5年的他莫昔芬治疗;5年的芳香化酶抑制剂 vs 2-3年他莫昔芬+随后芳香化酶抑制剂治疗(总共5年时间);2-3年他莫昔芬+随后芳香化酶抑制剂治疗(总共5年时间) vs 5年

Baidu
map
Baidu
map
Baidu
map